The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)
In this presentation Dr Cottel shares case studies of patients:
36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly.
John Robinson, NMD - Thyroid Autoimmunity Causal Relationships (2017 Conference) (LDN, low dose naltrexone)
Paul Anderson, NMD - Advances in healing Thyroid Disorders (2017 Conference) (LDN, low dose naltrexone)
In this presentation Dr Paul Anderson, from Seattle Washington, discusses the use of Low Dose Naltrexone immunotherapy in thyroid conditions.
Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)
Terry from the US shares her experience of LDN for Graves Disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Terry from the United States shares his Graves Disease and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Dr Steven Tenenbaum - 28th July 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Steven Tenenbaum shares his LDN Experience on the LDN Radio Show
Dr Steven Tenenbaum shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Bev uses LDN for Graves, Psoriasis and Psoriatic Arthritis - 12th August (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Bev from Israel shares her Graves Disease and Psoriasis and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Ani talks about LDN for Hashimoto's - 5th August 2020 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Ani shares her Hashimoto's and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Paul Anderson, NMD - Case Studies (2017 Conference) (LDN, low dose naltrexone)
The first case is an oncology patient, a 47 year old female with colorectal cancer. This lady presented herself while halfway through standard cancer treatment. Dr Anderson added many adjunct therapies as well as Low Dose Naltrexone and the patients tumour markers reduced for the first time.